Northwest Biotherapeutics (NWBO)

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	2.94 mm	2.94 mm	2.94 mm	2.94 mm	2.94 mm	2.94 mm
Cash burn (monthly)	(no burn)	263.17 k	4.93 mm	5.26 mm	2.74 mm	4.48 mm
Cash used (since last report)	n/a	1.12 mm	21.07 mm	22.47 mm	11.72 mm	19.14 mm
Cash remaining	n/a	1.82 mm	-18.13 mm	-19.53 mm	-8.78 mm	-16.20 mm
Runway (months of cash)	n/a	6.9	-3.7	-3.7	-3.2	-3.6

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q3 2024

NWBO institutional ownership history Ownership history

0.0% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	2	3	-33.3%
Opened positions	1	2	-50.0%
Closed positions	2	5	-60.0%
Increased positions	0	0
Reduced positions	0	0

13F shares	Current	Prev Q	Change
Total value	4.00 k	15.00 k	-73.3%
Total shares	15.01 k	34.26 k	-56.2%
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
AlphaMark Advisors	14.01 k	$4.00 k	0.0%
Coston, McIsaac & Partners	1.00 k	$0.00	NEW

Largest transactions	Shares	Bought/sold	Change
Lee Danner & Bass	0.00	-20.00 k	EXIT
Coston, McIsaac & Partners	1.00 k	+1.00 k	NEW
Hantz Financial Services	0.00	-250.00	EXIT
AlphaMark Advisors	14.01 k	0.00	0.0%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

NWBO insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
29 Aug 24	Boynton Alton L	STOCK OPTIONS COMMON STOCK PAR VALUE $0.001	Gift	Dispose G	No	No	0.23	1,000,000	230.00 k	967,065
9 Aug 24	Bosch Marnix L	STOCK OPTIONS COMMON STOCK PAR VALUE $0.001	Gift	Dispose G	No	No	0.35	3,000,000	1.05 mm	4,549,157
8 Aug 24	Boynton Alton L	STOCK OPTIONS COMMON STOCK PAR VALUE $0.001	Gift	Dispose G	No	No	0.23	1,000,000	230.00 k	1,967,065
26 Jul 24	Navid Malik	Stock Option Common Stock	Sell	Dispose S	No	No	0.38	657,895	250.00 k	23,339,393
17 Nov 23	Navid Malik	Common Stock	Sell	Acquire S	No	No	0.819	295,000	241.60 k	0
17 Nov 23	Navid Malik	Common Stock	Sell	Acquire S	No	No	0.823	150,000	123.45 k	295,000
16 Nov 23	Navid Malik	Common Stock	Sell	Acquire S	No	No	0.835	125,000	104.38 k	445,000

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

Press releases

From Benzinga Pro

Investors Watching Two Small-Caps for News on Potential Major Advancements in Cancer Treatments

13 Jan 25

Both %ShuttlePharmaceuticals (NASDAQ:SHPH) and %NorthwestBiotherapeutics (OTC:NWBO) are companies that have attracted investor attention due to their promising %Cancer treatments. Both have relatively small market caps,

Northwest Biotherapeutics Announces $5 Million Convertible Note Financing and Standby Facility for Up to $50 Million Additional Financing

26 Dec 24

BETHESDA, Md., Dec. 26, 2024 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB:NWBO) (the "Company" or "NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid